← Eichor
Condition: Psma Pet Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Psma Pet

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05616650PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07691697Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Phase N/A · 9 location(s) · Xijing Hospital · NCT07553780Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06305390PSMA PET for Surveillance After Focal Therapy
NA · 1 location(s) · University of Chicago · NCT07115914The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
Phase N/A · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT05097274Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07686016Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06546267A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer
Phase 1 · 2 location(s) · Philogen S.p.A. · NCT07600554Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
NA · 1 location(s) · University Health Network, Toronto · NCT06508567Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Phase 2 · 4 location(s) · Martin T. King, MD, PhD · NCT07393867Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance
NA · 4 location(s) · Weill Medical College of Cornell University · NCT05948657Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
Phase 2 · 2 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT0589338124 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
NA · 1 location(s) · IRCCS San Raffaele · NCT05936736PSMA PET Response Guided SabR in High Risk Pca
Phase 1 · 2 location(s) · University of Texas Southwestern Medical Center · NCT06044857Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-I
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT04402151Breast Cancer PSMA PET
EARLY_Phase 1 · 1 location(s) · Ahmad Shariftabrizi · NCT06586047Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT05010343PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prost
NA · 1 location(s) · German Oncology Center, Cyprus · NCT07568613Ultralow Dose PET Imaging for PSMA Expression
Phase 2 · 1 location(s) · Akiva Mintz · NCT06904313Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan
Phase 2 · 9 location(s) · Convergent Therapeutics · NCT0654946568Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Phase 2/Phase 3 · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07209878Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Phase 2/Phase 3 · 9 location(s) · Cancer Research Antwerp · NCT06282588Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
Phase 3 · 5 location(s) · Stefan Carlsson · NCT04794777Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07285057Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT06062745
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.